BioCentury
ARTICLE | Financial News

Inhale edges down on Exubera news

May 17, 2002 7:00 AM UTC

INHL was off $0.50 to $7.35 on Friday after partner Pfizer (PFE) in an amended 10-Q filing removed Exubera dry powder pulmonary insulin from a list of anticipated regulatory 2002 filings. The product ...